Preparation and anti‐tumor efficiency evaluation of doxorubicin‐loaded bacterial magnetosomes: Magnetic nanoparticles as drug carriers isolated from Magnetospirillum gryphiswaldense

Bacterial magnetosomes (BMs) are commonly used as vehicles for certain enzymes, nucleic acids and antibodies, although they have never been considered drug carriers. To evaluate the clinical potential of BMs extracted from Magnetospirillum gryphiswaldense in cancer therapy, doxorubicin (DOX) was loaded onto the purified BMs at a ratio of 0.87 ± 0.08 mg/mg using glutaraldehyde. The DOX‐coupled BMs (DBMs) and BMs exhibited uniform sizes and morphology evaluated by TEM. The diameters of DBMs and BMs obtained by AFM were 71.02 ± 6.73 and 34.93 ± 8.24 nm, respectively. The DBMs released DOX slowly into serum and maintained at least 80% stability following 48 h of incubation. In vitro cytotoxic tests showed that the DBMs were cytotoxic to HL60 and EMT‐6 cells, manifested as inhibition of cell proliferation and suppression in c‐myc expression, consistent with DOX. These observations depicted in vitro antitumor property of DBMs similar to DOX. The approach of coupling DOX to magnetosomes may have clinical potential in anti‐tumor drug delivery. Biotechnol. Bioeng. 2008;101: 1313–1320. © 2008 Wiley Periodicals, Inc.

[1]  J. Wei,et al.  Purified and sterilized magnetosomes from Magnetospirillum gryphiswaldense MSR‐1 were not toxic to mouse fibroblasts in vitro , 2007, Letters in applied microbiology.

[2]  Su-il Park,et al.  Preparation of poly ɛ-caprolactone nanoparticles containing magnetite for magnetic drug carrier , 2006 .

[3]  K. Neoh,et al.  Synthesis and in vitro anti-cancer evaluation of tamoxifen-loaded magnetite/PLLA composite nanoparticles. , 2006, Biomaterials.

[4]  T. Schmitz-Rode,et al.  Thermosensitive magnetic polymer particles as contactless controllable drug carriers , 2006 .

[5]  J. Dobson.  Magnetic nanoparticles for drug delivery , 2006 .

[6]  Chi‐Hwa Wang,et al.  In vitro study of anticancer drug doxorubicin in PLGA-based microparticles. , 2005, Biomaterials.

[7]  M. Hopkin.  Magnet-making bacteria could target tumours , 2004, Nature.

[8]  U. Heyen,et al.  Nanostructure and field-induced arrangement of magnetosomes studied by SANSPOL , 2004 .

[9]  L. Gianni,et al.  Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity , 2004, Pharmacological Reviews.

[10]  D. Schüler,et al.  Biochemical and Proteomic Analysis of the Magnetosome Membrane in Magnetospirillum gryphiswaldense , 2004, Applied and Environmental Microbiology.

[11]  M. Bally,et al.  In Vitro and in Vivo Characterization of Doxorubicin and Vincristine Coencapsulated within Liposomes through Use of Transition Metal Ion Complexation and pH Gradient Loading , 2004, Clinical Cancer Research.

[12]  Q. Pankhurst,et al.  TOPICAL REVIEW: Applications of magnetic nanoparticles in biomedicine , 2003 .

[13]  C. Bárcena,et al.  APPLICATIONS OF MAGNETIC NANOPARTICLES IN BIOMEDICINE , 2003 .

[14]  T. Matsunaga,et al.  SNP detection in transforming growth factor-beta1 gene using bacterial magnetic particles. , 2003, Biosensors & bioelectronics.

[15]  Haruko Takeyama,et al.  Fully automated immunoassay system of endocrine disrupting chemicals using monoclonal antibodies chemically conjugated to bacterial magnetic particles , 2003 .

[16]  Dehua Zhao,et al.  Submerged culture of Magnetospirillum gryphiswaldense under N2-fixing condition and regulation of activity of nitrogen fixation , 2002 .

[17]  D. Mondal,et al.  Zidovudine (AZT) treatment suppresses granulocyte-monocyte colony stimulating factor receptor type alpha (GM-CSFR alpha) gene expression in murine bone marrow cells. , 2002, Life sciences.

[18]  M. Garnett,et al.  Targeted drug conjugates: principles and progress. , 2001, Advanced drug delivery reviews.

[19]  S. A. Gómez-Lopera,et al.  Synthesis and characterization of poly(ethyl-2-cyanoacrylate) nanoparticles with a magnetic core. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[20]  Robert Langer,et al.  pH-Responsive Polymer Microspheres: Rapid Release of Encapsulated Material within the Range of Intracellular pH** , 2001 .

[21]  Lai Qiong Yu,et al.  Study of preparation and properties on magnetization and stability for ferromagnetic fluids , 2000 .

[22]  M. Runge,et al.  Doxorubicin-Induced Cardiomyopathy , 2000 .

[23]  R. B. Frankel,et al.  Bacterial magnetosomes: microbiology, biomineralization and biotechnological applications , 1999, Applied Microbiology and Biotechnology.

[24]  Teruo Okano,et al.  Thermo-responsive polymer nanoparticles with a core-shell micelle structure as site-specific drug carriers , 1997 .

[25]  P. Singal,et al.  Adriamycin cardiomyopathy: pathophysiology and prevention , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[26]  A. Schally,et al.  High yield conversion of doxorubicin to 2-pyrrolinodoxorubicin, an analog 500-1000 times more potent: structure-activity relationship of daunosamine-modified derivatives of doxorubicin. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[27]  C. Nakamura,et al.  Application of bacterial magnetic particles as novel DNA carriers for ballistic transformation of a marine cyanobacterium , 1995 .

[28]  R. Frankel,et al.  Electron microscopic studies of magnetosomes in magnetotactic bacteria , 1994, Microscopy research and technique.

[29]  M. Sarikaya,et al.  An introduction to biomimetics: A structural viewpoint , 1994, Microscopy research and technique.

[30]  N. Nakamura,et al.  Highly sensitive detection of allergen using bacterial magnetic particles , 1993 .

[31]  T. Matsunaga,et al.  Immunoassay method for the determination of immunoglobulin G using bacterial magnetic particles. , 1991, Analytical chemistry.

[32]  R. Blakemore,et al.  Characterization of the bacterial magnetosome membrane , 1988, Journal of bacteriology.

[33]  T. Matsunaga,et al.  Use of magnetic particles isolated from magnetotactic bacteria for enzyme immobilization , 1987, Applied Microbiology and Biotechnology.

[34]  P. Walter,et al.  Photocrosslinking of the signal sequence of nascent preprolactin to the 54-kilodalton polypeptide of the signal recognition particle. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[35]  E. Goormaghtigh,et al.  Role of the quinone structure in the mitochondrial damage induced by antitumor anthracyclines , 1983, FEBS letters.

[36]  R. Blakemore,et al.  Ultrastructure of a magnetotactic spirillum , 1980, Journal of bacteriology.

[37]  K. Widder,et al.  Magnetic Microspheres: A Model System for Site Specific Drug Delivery in Vivo 1 , 1978, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[38]  C. I. Bliss.  THE CALCULATION OF THE DOSAGE-MORTALITY CURVE , 1935 .

[39]  S. Jian,et al.  The Magnetosomes of Magnetotactic Bacteria May be Used as Drug-carriers for Targeted Therapy , 2007 .

[40]  V. Torchilin,et al.  Drug targeting. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[41]  D. G. Smith,et al.  THE CELLULAR LOCATION OF ANTIGENS IN STREPTOCOCCI OF GROUPS D, N AND Q. , 1964, Journal of general microbiology.